600351 logo

Yabao Pharmaceutical Group Co., Ltd Stock Price

SHSE:600351 Community·CN¥4.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600351 Share Price Performance

CN¥6.50
0.83 (14.64%)
CN¥6.50
0.83 (14.64%)
Price CN¥6.50

600351 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet, good value and pays a dividend.

1 Risk
2 Rewards

Yabao Pharmaceutical Group Co., Ltd Key Details

CN¥2.3b

Revenue

CN¥1.1b

Cost of Revenue

CN¥1.2b

Gross Profit

CN¥932.8m

Other Expenses

CN¥222.8m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 25, 2026
0.32
50.84%
9.80%
3.6%
View Full Analysis

About 600351

Founded
1978
Employees
3611
CEO
Wei Ren
WebsiteView website
www.yabao.com.cn

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.

Recent 600351 News & Updates

Recent updates

No updates